01:14 PM EDT, 10/28/2025 (MT Newswires) -- Philips (PHG) shares were down 6% in recent Tuesday trading after the US Food and Drug Administration said that the company's ultrasound and medical device plants in the US and the Netherlands were found to be in violation of quality system requirements.

The FDA inspected facilities in Bothell, Washington, from Jan. 13 to Jan. 31, in Reedsville, Pennsylvania, from Jan. 23 to Mar. 13, and in Eindhoven, Netherlands, from Jan. 13 to Jan. 17, the agency said.

The regulator said the facilities failed to comply with current good manufacturing practices under federal quality system regulations, rendering the devices adulterated.

Philips submitted multiple responses between February and August addressing the FDA's inspectional observations at all three sites, the regulator said.

Price: 27.17, Change: -1.72, Percent Change: -5.95